|
ASRM: Ovarian Cancer Risk Increased After In Vitro Fertilization
SAN FRANCISCO (MedPage Today) -- In vitro fertilization is associated with an increased risk of ovarian malignancies, particularly borderline tumors -- but the absolute risk of these uncommon malignancies remains small, a large study showed.
ASRM: Studies Suggest Possible Fertility Risk with Bisphenol A Exposure
SAN FRANCISCO (MedPage Today) -- Several new studies suggest that exposure to bisphenol A may reduce fertility in both men and women, but this association needs to be further examined, researchers cautioned.
Smoking During Pregnancy May Induce Arterial Damage in Offspring
UTRECHT, The Netherlands (MedPage Today) -- Mothers or fathers who smoke during pregnancy may create lasting vascular damage for their children, researchers here found.
Bariatric Surgery May Decrease Pregnancy Complication Risks
LOS ANGELES (MedPage Today) -- If obese women have bariatric surgery before becoming pregnant, they can reduce their risks of maternal and neonatal complications, suggested researchers here.
Assisted Reproduction Associated with Birth Defects
ATLANTA (MedPage Today) -- Assisted reproductive technology is associated with a two- to four-fold increase in the risk of some birth defects, researchers here said.
ASRM: Fertility Preservation Available for Broader Range of Patients
SAN FRANCISCO (MedPage Today) -- The use of fertility preservation procedures is rapidly expanding beyond the adult cancer population, with non-cancerous conditions now the fastest growing indication, according to a recent study.
ASRM: New Embryo Screening Technique Boosts IVF Pregnancy Rates
SAN FRANCISCO (MedPage Today) -- A new method of screening embryos before implantation for in vitro fertilization can achieve a "remarkable" increase in pregnancy rates by weeding out virtually all chromosome abnormalities, researchers said here.
FDA Okays Estrogen Cream for Dyspareunia
COLLEGEVILLE, Pa. (MedPage Today) -- The FDA has approved conjugated estrogen cream (Premarin) to treat dyspareunia under a less-frequent dosing regimen, drug maker Wyeth Pharmaceuticals announced.
|
